Oct 5, 2022, 14:19 PM
Keeping up to date on diabetes technology advances and knowing how to put them into practice is critical for diabetes care and education specialists. Learn more about a new ADCES resource and upcoming ADCES conference that can help you do just that.
Sep 28, 2022, 15:11 PM
It's estimated that more than 25% of the world’s adult population has some degree of Non-Alcoholic Fatty Liver Disease, with the vast majority undiagnosed and asymptomatic.
Sep 15, 2022, 09:20 AM
Connecting with local people is the best way to learn about a new culture, so the client is your best guide to learn about their culture and how to support their diabetes management in a culturally competent manner. Guest blogger Sandra Arevalo shares five recommendations for healthcare providers who are looking to increase cultural competency in easy, fun and interactive ways.
Aug 1, 2022, 10:19 AM
Sheryl Traficano outlines the efforts made by the CBDCE Board of Directors to address the impact of the COVID-19 pandemic on the ability of health care professionals pursuing the Certified Diabetes Care and Education Specialist® (CDCES®) credential.
Jul 25, 2022, 08:00 AM
There is no better place than the ADCES Annual Conference in Baltimore to learn about emerging science and research in diabetes care and education! Mark your calendar to attend one of the ADCES22 research-focused sessions at ADCES22.
Jul 18, 2022, 07:00 AM
Christina Dauer MPH, RDN, LDN, CDCES gives a preview of the ADCES22 sessions in the Diabetes in Practice track — created to help both new and seasoned DCESs develop skills in patient care, population health and advocacy.
Jul 13, 2022, 16:58 PM
Cardiovascular-specific knowledge helps the DCES treat the whole person. We know that having diabetes is a risk factor for ASCVD, microvascular and microvascular complications, heart failure and stroke, to name a few. Chris Memering, MSN, RN, CDCES, FADCES shares her thoughts on the importance of developing your cardiovascular expertise when working with people with diabetes.
Jul 6, 2022, 15:51 PM
In May 2022, the FDA approved another GLP-1 agonist, tirzepatide (Mounjaro ™) for the treatment of type 2 diabetes mellitus. Mark A. Smith, Jr., PharmD, CDCES, AFAA-CGFI summarize what diabetes care and education specialists need to know about this medication and its role in diabetes management and weight loss.
Jun 30, 2022, 16:15 PM
The Endocrine Society has updated their 2012 practice guideline that focuses on glycemic management in the hospital setting to address and incorporate emerging technology and current research. Kellie Antinori-Lent, MSN, RN, ACNS-BC, BC-ADM, CDCES, FADCES, shares highlights of the revision and why it's important for DCESs and the specialty.
Jun 27, 2022, 12:17 PM
The American College of Lifestyle Medicine (ACLM) recently published a consensus statement with the title Dietary Interventions to Treat Type 2 Diabetes in Adults with a Goal of Remission. Carrie Swift, MS, RDN, BC-ADM, CDCES, shares the highlights of the report in this blog post.